BBH

VanEck Vectors Biotech ETF

Up$132.19
+$1.24
(+0.95%)
As of 11:49:50 AM EDT | 11/12/19  |  Market Open

BBH Trading Data

Open

$130.89

Low Price

$130.89

High Price

$132.19

Previous Last Price

$130.95

Bid Size

$132 X 200

Ask Size

$132.08 X 100

BBH Portfolio Data

AUM

$347,644,300

Shares

2,647

PE Ratio

19.24

Price / Book Ratio

3.94

Expense Ratio

0.35

Net Asset Value

$131.36

Volume

Volume

2,257

Avg. Volume (YDT)

15,715

Dollar Volume

$220,547

Weekly Avg. Volume

9,977

Monthly Avg. Volume

12,919

Quarterly Avg. Volume

14,458

BBH Fund Description

The VanEck Vectors Biotech ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index, which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment. Expenses for BBH are capped contractually at 0.35% until at least February 1, 2018. Cap excludes certain expenses, such as interest.

BBH Chart

BBH Summary

Fund Family

Van Eck Associates

Tracks This Index

VanEck Vectors Biotech ETF

Inception Date

2011-12-21

Asset Class

Equity

Asset Class Size

Biotech

BBH Classification

Region (General)

North America

Region (Specific)

US

Sector

Health Care

Equity Index

Leveraged Family

BBH Technicals

Alpha

-9.18

Beta

1.29

Leverage

Long

Standard Deviation

4.92

BBH Dividends

Dividend Date

2018-12-20

Latest Dividend

5.551

Annual Dividend

5.55

Annual Dividend Rate

5.55

Annual Dividend Yield

4.23

BBH Performance

YTD Return

19.08%

1 Year Return

10.27%

3 Year Return

17.01%

5 Year Return

14.34%

10 Year Return

303.79%

BBH Related Articles

© 2019 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.